O'Brien Patrick's Form 4 filing
Arrowhead Pharmaceuticals, Inc. (ARWR) · filed Jan 6, 2023
- Accession no.
- 0001209191-23-002481
- Filed
- Jan 6, 2023
- Trade date
- Jan 5, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $560.9K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| O'Brien PatrickCIK 0001627183 | Officer (COO and General Counsel) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 5, 2023 | Common Stock | SSaleDisposed | −7,500 | $37.39 | −$280,425 | 420,875 | Direct | |
| Jan 5, 2023 | Common Stock | SSaleDisposed | −7,500 | $37.39 | −$280,425 | 413,375 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.